Ike: "Bananas are yellow."
hoffmann6383: "No apples are red!"
I NEVER said that NWBO was not seeking commercial manufacturing approval. I NEVER suggested that they were not doing the things necessary for approval. My question is "how does dribbling the release of TLD improve their chances of approval? Release of TLD and approval are, AFAIK, completely different processes."
You are ignoring the issue I am raising. The issue is with dribbling TLD out instead of doing what they said 30 months ago they were going to do, namely a flurry of PRs, and what they have suggested more recently that they would do, namely release the full data in a peer-reviewed journal article.
The more they make promises they don't keep, the more they put out PRs about presentations and hints about release of TLD and then don't support them, the more deadlines they miss, the more out-of-touch with investors they seem, the less people are going to be willing to buy their stock. And when they are stuck on the OTC, a lot of the big players, and even normal investors, are not going to touch them. So they can't afford to alienate the people who would normally be willing to buy.
They may have great reasons for what they do. They may be precluded from explaining what those reasons are (although I think that this latter is less likely). But until we know what happened and why, it is impossible to judge except by the results, which were not good. If there is ever an ASM, already a month late and no indication of when it will occur, then maybe we will know more.
In the meantime, it should concern NWBO when ardent supporters no longer believe what they say.
